R21 CA164970/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2012	4
2013	9
2014	5
2015	6
2016	6
2017	13
2018	4
2019	2
2020	6
2021	5
2022	4
2023	3
2024	1
2025	1

1

CD39 limits P2X7 receptor inflammatory signaling and attenuates sepsis-induced liver injury.

Savio LEB, de Andrade Mello P, Figliuolo VR, de Avelar Almeida TF, Santana PT, Oliveira SDS, Silva CLM, Feldbrügge L, Csizmadia E, Minshall RD, Longhi MS, Wu Y, Robson SC, Coutinho-Silva R. Savio LEB, et al. J Hepatol. 2017 Oct;67(4):716-726. doi: 10.1016/j.jhep.2017.05.021. Epub 2017 May 26. J Hepatol. 2017. PMID: 28554875 Free PMC article.

2

CD73 Inhibits cGAS-STING and Cooperates with CD39 to Promote Pancreatic Cancer.

Jacoberger-Foissac C, Cousineau I, Bareche Y, Allard D, Chrobak P, Allard B, Pommey S, Messaoudi N, McNicoll Y, Soucy G, Koseoglu S, Masia R, Lake AC, Seo H, Eeles CB, Rohatgi N, Robson SC, Turcotte S, Haibe-Kains B, Stagg J. Jacoberger-Foissac C, et al. Cancer Immunol Res. 2023 Jan 3;11(1):56-71. doi: 10.1158/2326-6066.CIR-22-0260. Cancer Immunol Res. 2023. PMID: 36409930 Free PMC article.

3

Ectonucleotidases in Intestinal and Hepatic Inflammation.

Vuerich M, Robson SC, Longhi MS. Vuerich M, et al. Front Immunol. 2019 Mar 19;10:507. doi: 10.3389/fimmu.2019.00507. eCollection 2019. Front Immunol. 2019. PMID: 30941139 Free PMC article. Review.

4

Purinergic signaling by TCRαβ⁺ double-negative T regulatory cells ameliorates liver ischemia-reperfusion injury.

Jin H, Li M, Wang X, Yang L, Zhong X, Zhang Z, Han X, Zhu J, Li M, Wang S, Robson SC, Sun G, Zhang D. Jin H, et al. Sci Bull (Beijing). 2025 Jan 30;70(2):241-254. doi: 10.1016/j.scib.2024.11.039. Epub 2024 Nov 28. Sci Bull (Beijing). 2025. PMID: 39658411 Free article.

5

Beyond ecto-nucleotidase: CD39 defines human Th17 cells with CD161.

Bai A, Robson S. Bai A, et al. Purinergic Signal. 2015 Sep;11(3):317-9. doi: 10.1007/s11302-015-9457-4. Epub 2015 Jun 10. Purinergic Signal. 2015. PMID: 26059452 Free PMC article. Review.

6

Ectonucleotidase Modulation of Lymphocyte Function in Gut and Liver.

Savio LEB, Robson SC, Longhi MS. Savio LEB, et al. Front Cell Dev Biol. 2021 Jan 21;8:621760. doi: 10.3389/fcell.2020.621760. eCollection 2020. Front Cell Dev Biol. 2021. PMID: 33553158 Free PMC article. Review.

7

Pathological roles of purinergic signaling in the liver.

Vaughn BP, Robson SC, Burnstock G. Vaughn BP, et al. J Hepatol. 2012 Oct;57(4):916-20. doi: 10.1016/j.jhep.2012.06.008. Epub 2012 Jun 16. J Hepatol. 2012. PMID: 22709619 Free PMC article. Review.

8

Purinergic signaling in liver disease.

Vaughn BP, Robson SC, Longhi MS. Vaughn BP, et al. Dig Dis. 2014;32(5):516-24. doi: 10.1159/000360498. Epub 2014 Jul 14. Dig Dis. 2014. PMID: 25034284 Free PMC article. Review.

9

Control of Gut Inflammation by Modulation of Purinergic Signaling.

Vuerich M, Mukherjee S, Robson SC, Longhi MS. Vuerich M, et al. Front Immunol. 2020 Sep 25;11:1882. doi: 10.3389/fimmu.2020.01882. eCollection 2020. Front Immunol. 2020. PMID: 33072065 Free PMC article. Review.

10

Regulation of the T Cell Response by CD39.

Takenaka MC, Robson S, Quintana FJ. Takenaka MC, et al. Trends Immunol. 2016 Jul;37(7):427-439. doi: 10.1016/j.it.2016.04.009. Epub 2016 May 25. Trends Immunol. 2016. PMID: 27236363 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

59 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

59 results

Results by year